Summary
- Current Price
- As of today, AVTX price is $14.99, up +0.27% on
- Current Price All-Time High
- AVTX price is currently -99.93% below its historical high of $22,032.00 set on
- Market Cap
- AVTX current market cap is $804M, up +246.88% over the past 365 days
- Revenue
- AVTX current annual revenue is $59.00K, down -86.62% year-over-year
- Next Earnings
- The next earnings release for AVTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Avalo Therapeutics, Inc. |
| Ticker | NASDAQ: AVTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | avalotx.com |
| Employees | 23 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $14.99 | |
| Price, 1D Change | +0.27% | |
| $804M | ||
| - | ||
| - | ||
| 1.21 | ||
| $59.00K | ||
| Revenue, 1Y Change | -86.62% | |
| -$5.84 | ||
| EPS, 1Y Change | +72.08% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:240 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CERC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$5.84 | ||
| EPS Estimate | -$2.72 | N/A |
| EPS Est. Change | +53.36% | N/A |
| $59.00K | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $14.99 | |
| Price Target | $40.50 | - |
| Price Tgt. Change | +170.18% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.92 | -$20.91 | -261.83% | |
| -$5.91 | -$5.84 | +1.29% | |
| -$2.72 | N/A | +53.36% | |
| -$2.74 | N/A | +53.03% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $224.50K | $441.00K | +96.44% | |
| - | $59.00K | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $14.99 | |
| $16.73 | ||
| $18.16 | ||
| $16.67 | ||
| $17.33 | ||
| -$0.95 | ||
| 1.21 | ||
| $0.96 | ||
| 34.55 | ||
| 50.53% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $59.00K | ||
| -$5.84 | ||
| -$285.00K | ||
| -483.05% | ||
| -$72.93M | ||
| -123.60% | ||
| -$78.26M | ||
| -132.64% | ||
| -$72.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.03 | ||
| 8.14 | ||
| 8.14 | ||
| - | ||
| - | ||
| 7.48 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 13.63K | ||
| 1.79 | ||
| -4.45 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $83.05M | ||
| $98.37M | ||
| $117.70M | ||
| $105.29M | ||
| $34.65M | ||
| $12.94M | ||
| $2.43M | ||
| $392.00K | ||
| $137.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $78.32M | ||
| $72.64M | ||
| $344.00K | ||
| $0.00 | ||
| $344.00K | ||
| $0.00 | ||
| $165.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$51.46M | ||
| -$81.72M | ||
| $14.59M | ||
| $0.00 | ||
| -$51.46M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Leerink Partners | ||
| BTIG | → | |
| B of A Securities | ||
| Wedbush | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
No data
Screeners with AVTX
FAQ
- What is the ticker symbol for Avalo Therapeutics, Inc.?
- The ticker symbol for Avalo Therapeutics, Inc. is NASDAQ:AVTX
- Does Avalo Therapeutics, Inc. pay dividends?
- No, Avalo Therapeutics, Inc. does not pay dividends
- What sector is Avalo Therapeutics, Inc. in?
- Avalo Therapeutics, Inc. is in the Healthcare sector
- What industry is Avalo Therapeutics, Inc. in?
- Avalo Therapeutics, Inc. is in the Biotechnology industry
- What country is Avalo Therapeutics, Inc. based in?
- Avalo Therapeutics, Inc. is headquartered in United States
- When did Avalo Therapeutics, Inc. go public?
- Avalo Therapeutics, Inc. initial public offering (IPO) was on October 14, 2015
- Is Avalo Therapeutics, Inc. in the S&P 500?
- No, Avalo Therapeutics, Inc. is not included in the S&P 500 index
- Is Avalo Therapeutics, Inc. in the NASDAQ 100?
- No, Avalo Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Avalo Therapeutics, Inc. in the Dow Jones?
- No, Avalo Therapeutics, Inc. is not included in the Dow Jones index
- When was Avalo Therapeutics, Inc. last earnings report?
- Avalo Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Avalo Therapeutics, Inc. report earnings?
- The next expected earnings date for Avalo Therapeutics, Inc. is November 12, 2026
Data Sources & References
- AVTX Official Website www.avalotx.com
- AVTX Profile on Yahoo Finance finance.yahoo.com/quote/AVTX
- AVTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avtx